Carbon nanotube based betulin formulation shows better efficacy against Leishmania parasite

Parasitology International

Volumn 63, Issue 6, 2014, Pages 772-776

  Saudagar, Prakash ^a   Dubey, Vikash Kumar ^a  

^a INDIAN INSTITUTE OF TECHNOLOGY GUWAHATI   (India)

Author keywords

[No Author keywords available]

Indexed keywords

BETULIN; CARBON NANOTUBE; MULTI WALLED NANOTUBE; ANTIPROTOZOAL AGENT; TRITERPENE;

ANIMAL CELL; ANTIPROTOZOAL ACTIVITY; ARTICLE; CYTOTOXICITY; DRUG EFFICACY; DRUG FORMULATION; LEISHMANIA DONOVANI; LEISHMANIASIS; MACROPHAGE; NONHUMAN; PARASITE; SYNTHESIS; ANIMAL; CELL LINE; CELL SURVIVAL; CHEMISTRY; DRUG EFFECTS; HUMAN; LEISHMANIA; MEDICINAL CHEMISTRY; PARASITOLOGY;

ANIMALS; ANTIPROTOZOAL AGENTS; CELL LINE; CELL SURVIVAL; CHEMISTRY, PHARMACEUTICAL; HUMANS; LEISHMANIA; LEISHMANIA DONOVANI; LEISHMANIASIS; MACROPHAGES; NANOTUBES, CARBON; TRITERPENES;

EID: 84908320647     PISSN: 13835769     EISSN: 18730329     Source Type: Journal    
DOI: 10.1016/j.parint.2014.07.008     Document Type: Article

References (25)

1. Janknegt R., de Marie S., Bakker-Woudenberg I.A., Crommelin D.J. Liposomal and lipid formulations of amphotericin B. Clin. Pharmacokinet. 1992, 23:279-291.
2. Bianco A., Kostarelos K., Partidos C.D., Prato M. Biomedical applications of functionalised carbon nanotubes. Chem. Commun. 2005, 7:571-577.
3. Balasubramanian K., Burghard M. Chemically functionalized carbon nanotubes. Small 2005, 1:180-192.
4. Malarkey E.B., Parpura V. Carbon nanotubes in neuroscience. Acta Neurochir. Suppl. 2010, 106:337-341.
5. Kam N.W.S., Liu Z., Dai H. Carbon nanotubes as intracellular transporters for proteins and DNA: an investigation of the uptake mechanism and pathway. Angew. Chem. Int. Ed. 2006, 45:577-5781.
6. Yang R., Yang X., Zhang Z., Zhang Y., Wang S., Cai Z., et al. Single-walled carbon nanotubes-mediated in vivo and in vitro delivery of siRNA into antigen-presenting cells. Gene Ther. 2007, 14:1714-1723.
7. Harrison B.S., Atala A. Carbon nanotube applications for tissue engineering. Biomaterials 2007, 28:344-353.
8. Bandaru P.R. Electrical properties and applications of carbon nanotube structures. J. Nanosci. Nanotechnol. 2007, 7:1239-1267.
9. Cao Y., Liu S., Shen Q., Yan K., Li P.J., Xu J., et al. High- performance photoresponsive organic nanotransistors with single-layer graphenes as two-dimensional electrodes. Adv. Funct. Mater. 2009, 19:2743-2748.
10. Dua V., Surwade S.P., Ammu S., Agnihotra S.R., Jain S., Roberts K.E., et al. All-organic vapor sensor using inkjet-printed reduced graphene oxide. Angew. Chem. Int. Ed. Engl. 2010, 49:2154-2157.
11. Dumortier H., Lacotte S., Pastorin G., Marega R., Wu W., Bonifazi D., et al. Functionalized carbon nanotubes are non-cytotoxic and preserve the functionality of primary immune cells. Nano Lett. 2006, 6:1522-1528.
12. Nimmagadda A., Thurston K., Nollert M.U., McFetridge P.S. Chemical modification of SWNT alters in vitro cell-SWNT interactions. J. Biomed. Mater. Res. A 2006, 76:614-625.
13. Wu W., Wieckowski S., Pastorin G., Benincasa M., Klumpp C., Briand J.P., et al. Targeted delivery of amphotericin B to cells by using functionalized carbon nanotubes. Angew. Chem. Int. Ed. 2005, 44:6358-6362.
14. Liu Z., Sun X., Nakayama-Rathford N., Dai H. Supramolecular chemistry on water-soluble carbon nanotubes for drug loading and delivery. ACS Nano 2007, 1:50-56.
15. Saudagar P., Dubey V.K. Cloning, expression, characterization and inhibition studies on Trypanothione Synthetase, a drug target enzyme, from Leishmania donovani. Biol. Chem. 2011, 392:1113-1122.
16. Saudagar P, Dubey VK. Molecular Mechanisms of In vitro Betulin-Induced Apoptosis of Leishmania donovani, Am. J. Trop. Med. Hyg. 90 354-360.
17. Chowdhury S., Mukherjee T., Sengupta S., Chowdhury S.R., Mukhopadhyay S., Majumder H.K. Novel betulin derivatives as antileishmanial agents with mode of action targeting type Ib DNA topoisomerase. Mol. Pharmacol. 2011, 80:694-703.
18. Sahoo N.G., Cheng H.K.F., Li L., Chan S.H., Judeh Z., Zhao J. Specific functionalization of carbon nanotubes for advanced polymer nanocomposites. Adv. Funct. Mater. 2009, 19:3962-3971.
19. Sahoo N.G., Bao H., Pan Y., Pal M., Kakran M., Cheng H.K.F., et al. Functionalized carbon nanomaterials as nanocarriers for loading and delivery of a poorly water-soluble anticancer drug: a comparative study. Chem. Commun. 2011, 47:5235-5237.
20. Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J. Immunol. Methods 1983, 65:55-63.
21. Ali-Boucetta H., Al-Jamal K.T., McCarthy D., Prato M., Bianco A., Kostarelos K. Multiwalled carbon nanotube-doxorubicin supramolecular complexes for cancer therapeutics. Chem. Commun. 2008, 28:459-461.
22. Service R.F. Nanotechnology takes aim at cancer. Science 2005, 310:1132-1134.
23. Brigger I., Dubernet C., Couvreur P. NPs in cancer therapy and diagnosis. Adv. Drug Deliv. Rev. 2002, 54:631-651.
24. Shukla A.K., Patra S., Dubey V.K. Nanospheres encapsulating anti-leishmanial drugs for their specific macrophage targeting, reduced toxicity, and deliberate intracellular release. Vector Borne Zoonotic Dis. 2012, 12:953-960.
25. Shukla A.K., Patra S., Dubey V.K. Evaluation of selected antitumor agents as subversive substrate and potential inhibitor of trypanothione reductase: an alternative approach for chemotherapy of Leishmaniasis. Mol. Cell. Biochem. 2011, 352:261-270.